REFERENCES
- S. Benita, and M. Y. Levy. (1993). Submicron emulsion as colloidal drug carriers for intravenous administration: Comprehensive physicochemical characterization. J. Pharm. Sci. 82:1069–1079.
- M. C. Bissery, D. Guenar, F. Gueritte-Voegelein, and F. Lavelle. (1991). Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51:4845–4852.
- G. Capri, E. Terenzi, F. Fulfaro, and L. Gianni. (1996). The role of taxanes in the treatment of breast cancer. Semin. Oncol. 23:68–75.
- R. H. Earhart. (1999). Docetaxel (taxotere): Preclinical and general clinical information. Semin. Oncol. 26:8–13.
- B. Fulton, and C. M. Spencer. (1996). Docetaxel, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer. Drugs 5:1075–1092.
- P. Y. Grosse, F. Bressolle, and F. Pinguet. (1998). In vitro modulation of doxorubicin and docetaxel antitumor activity by methyl-β-cyclodextrin. Eur. J. Cancer 34:168–174.
- P. Gueritte-Voegelein, D. Guenard, F. Lavelle, M. T. Le Goff, L. Mangatal, and P. Potier. (1991). Relationships between the structure of Taxol analogues and their antimitotic activity. J. Med. Chem. 34:992–998.
- Y. X. Guo, D. J. Zhang, H. Wang, Z. L. Xiu, L. X. Wang, and H. B. Xiao. (2007). Hydrolytic kinetics of lithospermic acid B extracted from roots of salvia miltiorrhiza. J. Pharma. Biomed. Anal 43:435–439.
- H. Hamada, K. Ishiara, N. Masuoka, K. Mikuni, and N. Nakajima. (2006). Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins. J. Biosci. Bioeng. 102:369–371.
- J. Han, S. S. Davis, C. Papandreou, C. D. Melia, and C. Washington. (2004). Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability. Pharm. Res. 21:1573–1580.
- M. L. Immordino, P. Brusa, S. Arpicco, B. Stella, F. Dosio, and L. Cattel. (2003). Preparation, characteration, cytotoxicity, and pharmacokinetics of liposomes containing docetaxel. J. Control Release 91:417–429.
- M. Y. Levy, and S. Benita. (1989). Design and characterization of a submicron o/w emulsion of diazepam for parenteral use. Int. J. Pharm. 54:103–112.
- W. J. Loos, J. Verweij, K. Nooter, G. Stoter, and A. Sparreboom. (1997). Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography. J. Chromatogr. B. Biomed. Sci. Appl. 693:437–441.
- B. B. Lundberg. (1997). A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol). J. Pharm. Pharmacol. 49:16–21.
- B. B. Lundberg, V. Risovic, M. Ramaswamy, and K. M. Wasan. (2003). A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J. Control Release 86:93–100.
- T. Musumeci, C. A. Ventura, I. Giannone, B. Ruozi, L. Montenegro, R. Pingatello, and G. Puglisi. (2006). PLA/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm. 325:172–179.
- A. J. Prankerd, and V. J. Stella. (1990). The use of oil-in-water emulsion as a vehicle for parenteral drug administration. J. Parenter. Sci. Technol. 44:139–149.
- I. Ringel, and S. B. Horwitz. (1991). Studies with RP 56976 (Taxotere): A semisynthetic analog of Taxol. J. Natl. Cancer Inst. 83:288–291.
- E. K. Rowinsky. (1997). The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med. 48:353–374.
- P. B. Schiff, J. Fant, and S. B. Horwitz. (1979). Promotion of microtubule assembly in vitro by Taxol. Nature 277:665–667.
- B. D. Tarr, T. G. Sanbandam, and S. H. Yalkowsky. (1987). A new parenteral emulsion for the administration of taxol. Pharm. Res. 4:162–165.
- T. Tokumura, T. Ichikawa, N. Sugawara, K. Tatsuishi, M. Kayano, Y. Machida, H. Hoshida, and T. Nagai. (1985). Kinetics of degradation of cinnarizine in aqueous solution. Chem. Pharm. Bull. 33:2069–2072.
- U. Vaishampayan, R. E. Parchment, B. R. Jasti, and M. Hussain. (1999). Taxanes: An overview of the pharmacokinetics and pharmacodynamics. Urology 54:22–29.
- J. J. Wang, K. C. Sung, O. Y. Hu, C. H. Yeh, and J. Y. Fang. (2006). Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J. Control Release 115:140–149.
- Y. Wang, and A. L. Cory. (1999). A novel stable supersaturated submicron lipid emulsion of tirilazad. Pharm. Dev. Technol. 4:333–345.
- A. Wretlind. (1981). Development of fat emulsion. JPEN J. Parenter. Enteral. Nutr. 5:230–235.